All Product News

East Windsor, N.J. – Aurobindo Pharma Limited has received final approval from U.S. Food and Drug Administration for its Abbreviated New Drug Application Perampanel Tablets, 2 mg, 4 mg, 6 mg, 8 mg, 10 mg, and 12 mg. Aurobindo Pharma’s Perampanel Tablets, are an AB-rated generic equivalent to the reference listed drug (RLD), Fycompa® Tablets, […]

East Windsor, N.J. – Aurobindo Pharma Limited has received final approval from U.S. Food and Drug Administration for its Abbreviated New Drug Application Metronidazole Vaginal Gel, 0.75%. Aurobindo Pharma’s Metronidazole Vaginal Gel, are an AB-rated generic equivalent to the reference listed drug (RLD), MetroGel® Vaginal Gel, manufactured by Bausch Health US, LLC. Metronidazole Vaginal Gel […]

East Windsor, N.J. – Aurobindo Pharma Limited has received final approval from U.S. Food and Drug Administration for its Abbreviated New Drug Application Cyclosporine Capsules USP (Modified) (Soft Gelatin Capsules), 25 mg, 50 mg, and 100 mg. Aurobindo Pharma’s Cyclosporine Capsules USP (Modified), are an AB-rated generic equivalent to the reference listed drug (RLD), Neoral® […]

East Windsor, N.J. – Aurobindo Pharma Limited has received final approval from U.S. Food and Drug Administration for its Abbreviated New Drug Application Isotretinoin Capsules USP, 20 mg, 30 mg, and 40 mg. Aurobindo Pharma’s Isotretinoin Capsules USP, are an AB-rated generic equivalent to the reference listed drug (RLD), Accutane® Capsules, manufactured by Hoffmann La […]

East Windsor, N.J. – Aurobindo Pharma Limited has received final approval from U.S. Food and Drug Administration for its Abbreviated New Drug Application Sacubitril and Valsartan Tablets, 24 mg/26 mg, 49 mg/51 mg, and 97 mg/103 mg. Aurobindo Pharma’s Sacubitril and Valsartan Tablets, are an AB-rated generic equivalent to the reference listed drug (RLD), Entresto® […]

East Windsor, N.J. – Aurobindo Pharma Limited has received final approval from U.S. Food and Drug Administration for its Abbreviated New Drug Application Brivaracetam Oral Solution, 10 mg/mL. Aurobindo Pharma’s Brivaracetam Oral Solution, are an AB-rated generic equivalent to the reference listed drug (RLD), Briviact® Oral Solution, manufactured by UBC, Inc. Brivaracetam Oral Solution are […]

East Windsor, N.J. – Aurobindo Pharma Limited has received final approval from U.S. Food and Drug Administration for its Abbreviated New Drug Application Vancomycin Hydrochloride for Oral Solution USP, 25 mg/mL and 50 mg/mL. Aurobindo Pharma’s Vancomycin Hydrochloride for Oral Solution USP, are an AB-rated generic equivalent to the reference listed drug (RLD), Firvanq® for […]

East Windsor, N.J. – Aurobindo Pharma Limited has received final approval from U.S. Food and Drug Administration for its Abbreviated New Drug Application Eslicarbazepine Acetate Tablets, 200 mg, 400 mg, 600 mg and 800 mg. Aurobindo Pharma’s Eslicarbazepine Acetate Tablets,  are an AB-rated generic equivalent to the reference listed drug (RLD), Aptiom® Tablets, manufactured by […]

East Windsor, N.J. – Aurobindo Pharma Limited has received final approval from U.S. Food and Drug Administration for its Abbreviated New Drug Application Adapalene and Benzoyl Peroxide Topical Gel, 0.3%/2.5%. Aurobindo Pharma’s Adapalene and Benzoyl Peroxide Topical Gel,  are an AB-rated generic equivalent to the reference listed drug (RLD), Epiduo® Forte Topical Gel, manufactured by […]

East Windsor, N.J. – Aurobindo Pharma Limited has received final approval from U.S. Food and Drug Administration for its Abbreviated New Drug Application Bupropion Hydrochloride Extended-Release Tablets USP (XL), 150 mg and 300 mg. Aurobindo Pharma’s Bupropion Hydrochloride Extended-Release Tablets USP (XL),  are an AB-rated generic equivalent to the reference listed drug (RLD), Wellbutrin XL® […]

East Windsor, N.J. – Aurobindo Pharma Limited has received final approval from U.S. Food and Drug Administration for its Abbreviated New Drug Application Etodolac Tablets USP, 400 mg and 500 mg. Aurobindo Pharma’s Etodolac Tablets USP, are an AB-rated generic equivalent to the reference listed drug (RLD), Lodine® Tablets, manufactured by Wyeth Pharmaceuticals Inc. Etodolac […]

East Windsor, N.J. – Aurobindo Pharma Limited has received final approval from U.S. Food and Drug Administration for its Abbreviated New Drug Application Icosapent Ethyl Capsules, 1 gram. Aurobindo Pharma’s Icosapent Ethyl Capsules, are an AB-rated generic equivalent to the reference listed drug (RLD), Vascepa Capsules, manufactured by Amarin Pharmaceuticals Ireland, Limited. Icosapent Ethyl Capsules […]